Navigation Links
'Oncometabolite' linked with widespread alterations in gene expression
Date:1/18/2011

A new study finds that a metabolite commonly elevated in brain cancer and leukemia may promote tumorigenesis by altering the expression of a large number of genes. New research, published by Cell Press in the January 18th issue of the journal Cancer Cell, enhances the understanding of the link between metabolic deregulation and cancer and may help to guide development of new targeted cancer therapies.

More than 75% of low grade gliomas and secondary glioblastoma multiforme (GBM), and about 20% of acute myeloid leukemia (AML), exhibit mutations in genes for isocitrate dehydrogenase (IDH1 and IDH2). The tumor-derived mutations in IDH1 and IDH2 lead to loss of normal production of α-ketoglutarate (α-KG), which is required for over 60 enzymes known as dioxygenases, and a gain in the production of 2-hydroxygulatrate (2-HG), which is found at very low levels in normal cells.

"Although 2-HG has been proposed to be an 'oncometabolite', its mechanism of action is not known," explains senior study author, Dr. Yue Xiong from the University of North Carolina at Chapel Hill. "Previous work demonstrated that 2-HG and α-KG are structurally similar, suggesting that 2-HG might interfere with the ability of α-KG to bind to and activate dioxygenases." Dr. Xiong, co-authors Dr. Kun-Liang Guan from the University of California at San Diego and Dr. Shi-min Zhao from Fudan University in Shanghai, and their colleagues designed a series of experiments to uncover how 2-HG contributes to cancer and determine the functional relationship between α-KG reduction and 2-HG elevation.

The researchers discovered that 2-HG functioned as a competitive inhibitor of multiple α-KG-dependent dioxygenases. Some of these dioxygenases regulate methylation of histones, a group of proteins that contribute to the structural organization of chromatin, and methylation of DNA. Alteration of histone and DNA methylation is likely to have a substantial impact on regulation of gene expression and, quite possibly, promote tumor growth. The researchers also showed that a cell-permeable derivative of α-KG reversed the effects of 2-HG inhibition.

"Our findings support the notion that although D-2-HG may not play a significant role in the regulation of α-KG-dependent dioxygenases in normal cells because of its low level, it could play an important role under pathological conditions in tumor cells expressing mutated IDH1 or IDH2", concludes Dr. Xiong. "We also suggest that drugs mimicking α-KG merit exploration as a therapy for tumors that harbor an IDH1 or IDH2 mutation, either alone or in combination with inhibitors to reduce the 2-HG production."


'/>"/>

Contact: Elisabeth Lyons
elyons@cell.com
617-386-2121
Cell Press
Source:Eurekalert

Related medicine news :

1. High birth weight in First Nations babies linked to a higher risk of postneonatal death
2. Too Much TV May Be Linked to Heart Attack, Death Risk
3. High dietary fat, cholesterol linked to increased risk of breast cancer
4. Secondhand television exposure linked to eating disorders
5. Violence against mothers linked to 1.8 million female infant and child deaths in India
6. Tooth Loss May Be Linked to Memory Loss
7. Vitamins C and E linked to metabolic syndrome in low-income Ecuadorians
8. Infant hydrocephalus, seasonal and linked to farm animals in Uganda
9. Risk for alcoholism linked to risk for obesity
10. Chronic Nasal Congestion May Be Linked to Severe Asthma
11. Size of Key Brain Region Linked to Size of Your Social Network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... ... ... The number of adults 65 years or older is expected to more than ... the population are not well described. In a study published in The Journal of ... American Academy of Allergy, Asthma & Immunology (AAAAI), researchers identified factors associated with asthma-related ...
(Date:7/25/2017)... (PRWEB) , ... July 25, 2017 , ... ... Haller, to the sales department joining as Regional Account Manager for the Northeast ... contracted customers in the liquidation of their obsolete medical assets. , Jennifer joins ...
(Date:7/25/2017)... , ... July 25, 2017 , ... ... clients, today announced it will be exhibiting and providing demos of its smart ... Walter E. Washington Convention Center in Washington D.C. from August 3-6, 2017. , ...
(Date:7/25/2017)... , ... July 25, 2017 , ... ... as medical director. Dr. Negrette has more than a decade of experience in ... worked closely with individuals fighting addictions, eating disorders, psychotic and manic conditions, as ...
(Date:7/25/2017)... ... July 25, 2017 , ... SignatureCare Emergency Center – South Austin ... area 24 Hours a day. , The Emergency Room opened early ... been open four months now and things are running smoothly,” said Aaron Braun, SignatureCare ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... , July 11, 2017  Sysmex America, Inc., ... diagnostic testing equipment as well as middleware information ... way to make quality assurance easier and more ... is well known for the innovation that it ... Monitor elevates quality assurance processes to a new ...
(Date:7/10/2017)... , July 10, 2017  US medical equipment ... in 2021, according to Medical Equipment & ... by Freedonia Focus Reports. Continued increases in demand for ... aging of the population and supported by gains in ... equipment and supplies. New product introductions will also drive ...
(Date:7/10/2017)... 10, 2017  The tenth annual BioPharm America™ ... at the Sheraton Boston Hotel, September 26–27. ... to global decision makers and innovative biotech startup companies. ... leaders during two impactful days. BioPharm America is now ... additional networking opportunities with 4,500+ life science industry influencers ...
Breaking Medicine Technology: